Cart
sales@molnova.com
Radotinib
CAS No. 926037-48-1
Radotinib( IY-5511 )
Catalog No. M16635 CAS No. 926037-48-1
Radotinib, and sometimes referred to by its investigational name IY5511.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 110 | In Stock |
|
| 50MG | 178 | In Stock |
|
| 100MG | 335 | In Stock |
|
| 500MG | 782 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRadotinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionRadotinib, and sometimes referred to by its investigational name IY5511.
-
DescriptionRadotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors.
-
In Vitro——
-
In Vivo——
-
SynonymsIY-5511
-
PathwayTyrosine Kinase
-
TargetBcr-Abl
-
RecptorBcr-Abl1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number926037-48-1
-
Formula Weight530.5
-
Molecular FormulaC27H21F3N8O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC1=CN(C=N1)C1=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=NC=CN=C3)=C(C)C=C2)=CC(=C1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Heo SK, et al. PLoS One. 2015 Jun 12;10(6):e0129853.
molnova catalog
related products
-
Dasatinib monohydrat...
Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML).
-
ZM 306416
ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
-
PP1
PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
